Skip to main content
PMC home page
Gut logoLink to Gut
. 1991 Mar;32(3):252–255. doi: 10.1136/gut.32.3.252

Ranitidine in the treatment of non-steroidal anti-inflammatory drug associated gastric and duodenal ulcers.

M J Lancaster-Smith 1, M E Jaderberg 1, D A Jackson 1
PMCID: PMC1378828  PMID: 2013419

Abstract

In a multicentre study the effect of ranitidine on healing non-steroidal anti-inflammatory drug (NSAID) associated peptic ulcers was compared in a group of patients who had stopped NSAID treatment with another group who continued with NSAID treatment. A total of 190 patients with confirmed ulcers were randomised to continue or stop NSAID treatment. All patients in addition received ranitidine 150 mg twice daily. Patients were endoscopically monitored at four, eight, and 12 weeks. Gastric ulcers at eight weeks had healed in 63% of those taking NSAIDs compared with 95% of those who had stopped NSAID treatment. For duodenal ulcer the healing rates at eight weeks were 84% in the group continuing NSAIDs compared with 100% in those who stopped NSAIDs. The differences in healing rates were statistically significant for both gastric ulcer (p = 0.001) and for duodenal ulcer (p = 0.006). At 12 weeks, 79% of gastric ulcers and 92% of duodenal ulcers were healed in the group continuing with NSAIDs. All patients with gastric and duodenal ulcers who stopped taking NSAIDs were healed at 12 weeks. The study shows that ranitidine 150 mg twice daily effectively heals NSAID associated peptic ulcers. Healing is more successful when NSAID treatment stops but even if these drugs are continued, substantial healing rates are achievable.

Full text

PDF
252

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Coles L. S., Fries J. F., Kraines R. G., Roth S. H. From experiment to experience: side effects of nonsteroidal anti-inflammatory drugs. Am J Med. 1983 May;74(5):820–828. doi: 10.1016/0002-9343(83)91073-2. [DOI] [PubMed] [Google Scholar]
  2. Croker J. R., Cotton P. B., Boyle A. C., Kinsella P. Cimetidine for peptic ulcer in patients with arthritis. Ann Rheum Dis. 1980 Jun;39(3):275–278. doi: 10.1136/ard.39.3.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ehsanullah R. S., Page M. C., Tildesley G., Wood J. R. Prevention of gastroduodenal damage induced by non-steroidal anti-inflammatory drugs: controlled trial of ranitidine. BMJ. 1988 Oct 22;297(6655):1017–1021. doi: 10.1136/bmj.297.6655.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Geczy M., Peltier L., Wolbach R. Naproxen tolerability in the elderly: a summary report. J Rheumatol. 1987 Apr;14(2):348–354. [PubMed] [Google Scholar]
  5. Hawkey C. J., Rampton D. S. Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology. 1985 Nov;89(5):1162–1188. doi: 10.1016/0016-5085(85)90225-2. [DOI] [PubMed] [Google Scholar]
  6. Kelly K. A., Malagelada J. R. Medical and surgical treatment of chronic gastric ulcer. Clin Gastroenterol. 1984 May;13(2):621–634. [PubMed] [Google Scholar]
  7. Levine R. A., Schwartzel E. H. Effect of indomethacin on basal and histamine stimulated human gastric acid secretion. Gut. 1984 Jul;25(7):718–722. doi: 10.1136/gut.25.7.718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. LoIudice T. A., Saleem T., Lang J. A. Cimetidine in the treatment of gastric ulcer induced by steroidal and nonsteroidal anti-inflammatory agents. Am J Gastroenterol. 1981 Feb;75(2):104–110. [PubMed] [Google Scholar]
  9. Manniche C., Malchow-Møller A., Andersen J. R., Pedersen C., Hansen T. M., Jess P., Helleberg L., Rasmussen S. N., Tage-Jensen U., Nielsen S. E. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease. Gut. 1987 Feb;28(2):226–229. doi: 10.1136/gut.28.2.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Penston J., Wormsley K. G. Adverse reactions and interactions with H2-receptor antagonists. Med Toxicol. 1986 May-Jun;1(3):192–216. doi: 10.1007/BF03259837. [DOI] [PubMed] [Google Scholar]
  11. Peterson W. L., Elashoff J. Placebos in clinical trials of duodenal ulcer: the end of an era? Gastroenterology. 1980 Sep;79(3):585–588. [PubMed] [Google Scholar]
  12. Sauniere J. F., Sarles H., Attia Y., Lombardo A., Yoman T. N., Laugier R., Manlan K., Sahel J. Exocrine pancreatic function of children from the Ivory Coast compared to French children. Effect of kwashiorkor. Dig Dis Sci. 1986 May;31(5):481–486. doi: 10.1007/BF01320311. [DOI] [PubMed] [Google Scholar]
  13. Thomas J. M., Misiewicz G. Histamine H2-receptor antagonists in the short- and long-term treatment of duodenal ulcer. Clin Gastroenterol. 1984 May;13(2):501–541. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES